Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study.
Debureaux PE, Harel S, Parquet N, Lemiale V, Siguret V, Goubeau L, Morin F, Royer B, Cuccuini W, Elessa D, Theves F, Brignier AC, Azoulay E, Arnulf B, Talbot A. Debureaux PE, et al. Among authors: elessa d. Front Immunol. 2022 Dec 8;13:1069360. doi: 10.3389/fimmu.2022.1069360. eCollection 2022. Front Immunol. 2022. PMID: 36569885 Free PMC article.
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).
Elessa D, Zhao LP, de Oliveira RD, Maslah N, Soret-Dulphy J, Verger E, Marcault C, Parquet N, Fenaux P, Adès L, Raffoux E, Giraudier S, Fain O, Cassinat B, Kiladjian JJ, Mekinian A, Benajiba L. Elessa D, et al. Leukemia. 2023 Aug;37(8):1741-1744. doi: 10.1038/s41375-023-01967-0. Epub 2023 Jul 11. Leukemia. 2023. PMID: 37433887 No abstract available.
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Debureaux PE, Forgeard N, Elessa D, Harel S, Frenzel L, Royer B, Talbot A, Choquet S, Davi F, Nguyen-Khac F, Cuccuini W, Cheminant M, Bravetti C, Lazarian G, Kaltenbach S, Hermine O, Roos-Weil D, Espéli M, Balabanian K, Arnulf B. Debureaux PE, et al. Among authors: elessa d. Haematologica. 2024 Jan 1;109(1):325-330. doi: 10.3324/haematol.2023.283141. Haematologica. 2024. PMID: 37584289 Free PMC article. No abstract available.
TNF-α antagonist infliximab for aseptic abscess syndrome.
Elessa D, Thietart S, Corpechot C, Fain O, Mekinian A. Elessa D, et al. Presse Med. 2019 Dec;48(12):1579-1580. doi: 10.1016/j.lpm.2019.09.056. Epub 2019 Nov 19. Presse Med. 2019. PMID: 31757730 Review. No abstract available.
Developmental bifurcation of human T follicular regulatory cells.
Kumar S, Fonseca VR, Ribeiro F, Basto AP, Água-Doce A, Monteiro M, Elessa D, Miragaia RJ, Gomes T, Piaggio E, Segura E, Gama-Carvalho M, Teichmann SA, Graca L. Kumar S, et al. Among authors: elessa d. Sci Immunol. 2021 May 28;6(59):eabd8411. doi: 10.1126/sciimmunol.abd8411. Sci Immunol. 2021. PMID: 34049865
Inflammatory Waldenström Macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort.
Debureaux PE, Poulain S, Harel S, Passet M, Templé M, Friedrich C, Forgeard N, Elessa D, Plas W, Chat L, Lazarian G, Willems L, Royer B, Talbot A, Vaugeois T Dr, Theves F, Terré A, Brignier AC, Malphettes M, Krzisch D, Frenzel L, Davi F, Bravetti C, Nguyen-Khac F, Dupuis J, Cuccuini W, Bouscary D, Hermine O, Roos-Weil D, Kosmider O, Clappier E, Espéli M, Balabanian K, Arnulf B. Debureaux PE, et al. Among authors: elessa d. Blood. 2024 Nov 21:blood.2024025738. doi: 10.1182/blood.2024025738. Online ahead of print. Blood. 2024. PMID: 39571148
[Serum hyperviscosity syndrome: Update 2024].
Debureaux PE, Parquet N, Brignier AC, Elessa D, Lemiale V, Siguret V, Quintard PA, Harel S, Royer B, Arnulf B, Talbot A. Debureaux PE, et al. Among authors: elessa d. Rev Med Interne. 2024 Dec;45(12):759-766. doi: 10.1016/j.revmed.2024.07.008. Epub 2024 Aug 7. Rev Med Interne. 2024. PMID: 39117483 Review. French.
Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.
Theves F, Lahuna C, Mahévas T, Harel S, Royer B, Lemiale V, Brignier A, Parquet N, Jachiet M, Bouaziz JD, Elessa D, Arnulf B, Talbot A. Theves F, et al. Among authors: elessa d. J Eur Acad Dermatol Venereol. 2024 Jul 31. doi: 10.1111/jdv.20257. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39082873
12 results